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Article
Effects of malalignment and disease
activity on osteophyte formation in
knees of rheumatoid arthritis patients
Noriaki Okumura1,2 , Taku Kawasaki2, Mitsuhiko Kubo2,
Takafumi Yayama2 , Tomohiro Mimura2, Kosuke Kumagai2,
Tsutomu Maeda2 and Shinji Imai2
Abstract
Purpose: Rheumatoid arthritis (RA) patients with secondary osteoarthritis (OA) in a knee joint following a total
knee arthroplasty (TKA) procedure have been increasing. Here, we investigated osteophyte formation in knee joints
of RA patients and associated factors. Methods: We retrospectively examined findings of 35 knees in 30 RA
patients (26 females, 4 males; mean age: 63.0 years; median disease duration: 15 years) who underwent TKA,
including preoperative anteroposterior view radiographs of the knee joint. Using the ImageJ software package,
osteophyte size in the medial femur (MF), medial tibia (MT), lateral femur (LF), and lateral tibia (LT) regions was also
determined. Results: The mean femorotibial angle was 179, while Larsen grade was 2 in 1, 3 in 12, 4 in 18, and 5 in 2
patients. Osteophyte sizes in the MF, MT, LF, and LT regions were 37.2, 17.0, 27.2, and 4.57 mm2, respectively, and
significantly greater in the medial compartment (MC; MFþMT) than the lateral compartment (LC; LFþLT) (p < 0.001). In
varus cases, osteophyte size in the MC was significantly larger than normal and valgus cases (p ¼ 0.0016). Furthermore,
osteophyte size in the MC was negatively correlated with the inflammatory markers C-reactive protein (r ¼ 0.492,
p ¼ 0.0027) and erythrocyte sedimentation rate (r ¼ 0.529, p ¼ 0.0016), whereas that in the LC was negatively
correlated with disease activity (r ¼ 0.589, p ¼ 0.0023). Conclusion: Our results suggest that alignment and disease
activity influence osteophyte formation in RA patients, with secondary OA a more prominent symptom in RA patients
with controlled inflammation.
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Introduction
Rheumatoid arthritis (RA) is a chronic inflammatory auto-
immune disease characterized by persistent synovitis and
progressive destruction of cartilage and bones in multiple
joints, which subsequently induces impairment of activities
of daily living. Bone destruction is caused by an activation
of osteoclasts by receptor activator of nuclear factor kappa-
B ligand (RANKL), with erosion the most characteristic
radiographic finding. Larsen classification, the most stan-
dard radiographic image classification method for RA,1
classifies the degree of progress according to the presence
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and extent of bone erosion, or its absence, as well as bone
atrophy, joint space narrowing, and bone deformity.
Recently, the classification criteria for early diagnosis have
been revised,2 in which RA is diagnosed when atypical
bone erosion is present. On the other hand, radiographic
findings characteristic of osteoarthritis (OA) includes
osteophyte formation, in addition to joint space narrowing
and bone sclerosis. To distinguish OA from RA, it has been
reported that the sensitivity of diagnosis can be improved
by combining multiple findings, such as osteophyte forma-
tion and joint space narrowing.3 Recent studies that used
computed tomography (CT) images of fingers of RA
patients have shown that osteophyte proliferation increases
with age and disease duration as well as a correlation
between bone erosion and osteophyte formation.4 Those
findings indicate that secondary OA progresses, the same
as seen in RA.
Advancements in RA treatment in recent years with the
development of disease-modifying anti-rheumatic drugs
(DMARDs) have been remarkable, and symptoms of arthri-
tis nearly disappear in treated patients due to the strong
anti-inflammatory action of the drugs, with remission
achieved in many. As a result, the need for RA-related
surgery has shown annual decreases,5,6 especially knee sur-
gery and synovectomy7 procedures, because synovitis in
the knee joint of RA patients can now be treated with drugs.
On the other hand, it has also been reported that the inci-
dence of joint replacement surgery has not decreased,8
which could be due to secondary OA in the knee joint of
RA patients.
In the present study, we aimed to confirm secondary OA
progression in knee joints of RA patients by quantitative
evaluations of osteophyte size, considered to be a charac-
teristic finding in OA, using images obtained just prior to
undergoing total knee arthroplasty (TKA) surgery. We also
examined the relationship between osteophyte size and
patient background factors, disease activity, and degree
of inflammation.
Patients and methods
Patients
We retrospectively examined radiographs of 35 knees in
30 consecutive patients with RA who underwent TKA
from January 2013 to December 2016 and were
recruited from the RA Outpatients Unit at Shiga Univer-
sity of Medical Science Hospital. All patients fulfilled
the American College of Rheumatology (ACR) 1987
revised criteria9 for diagnosis of RA or ACR/European
League Against Rheumatism criteria 2010.2 Written
informed consent for data collection was obtained from
each in accordance with the Declaration of Helsinki.
This study was approved by the Shiga University Ethics
Committee (number 26-136).
Demographic and disease-related data
Patient demographicandclinical characteristics, includingage,
gender, disease duration, Steinbrocker criteria, glucocorticoid
dose, use of methotrexate (MTX) or biological DMARDs,
serum C-reactive protein (CRP) concentration, erythrocyte
sedimentation rate (ESR), simplified disease activity index
(SDAI), andmodifiedHealthAssessmentQuestionnaire score,
were obtained from the medical records (Table 1).
Radiographic assessment and osteophyte analysis
Standard anteroposterior (AP) radiographs of the knees
with a calibration ball and standing-view of the lower legs
were taken preoperatively in all patients. Structural damage
was assessed according to the method described by Larsen
et al.1 For osteophyte score, we used baseline AP radio-
graph images and graded each marginal osteophyte on a
scale of 0–3 according to the Osteoarthritis Research
Society International (OARSI) atlas.10 For each knee, the
following four sites were scored: medial tibia (MT), medial
femur (MF), lateral tibia (LT), and lateral femur (LF). Lar-
sen and OARSI grading were determined by two of the
authors (NO, KK), who were blinded to subject IDs and
background information. OARSI grading was nearly
matched (weighted kappa values in MF, MT, LF, and
LT: 0.956, 0.968, 0.971, and 0.981, respectively), and
instances of disagreement were resolved by consensus.
Osteophyte areas were quantified by three of the authors
(NO, KK, TY), each of whom are specialized orthopedic
surgeons. Freehand selections were made around osteo-
phytes in the following four sites: MT, MF, LT, and LF
(Image J, National Institutes of Health, Bethesda, MD)
(Figure 1). Osteophyte size was calculated using the size
of the calibration ball as a reference (diameter 25.4 mm).
Table 1. Characteristics of subjects.
N ¼ 35 knees (30 patients)
Age (years), mean + SD 63.0+ 9.80
Gender (female/male) 31/4 (26/4)
Disease duration (years) 15 (12–25.5)
RF positivity, n (%) 27/34 (79.4%)
ACPA positivity, n (%) 10/12 (83.3%)
MTX, n (%) 20 (57.1%)
MTX, dose (mg/W) 5.8+ 1.58
Oral GC, n (%) 18 (51.4%)
Oral GC, dose (mg/day) 4.28+ 1.01
Biologics 13 (37.1%)
IFX 2, ETN 9, CZP 1, TOF 1
CRP (mg/dl) 0.44 (0.20–2.01)
ESR (mm/h) 20.6 (14–37.4)
SDAI 12.09 (6.23–15.43) (n ¼ 25)
SD: standard deviation; RF: rheumatoid factor; ACPA: anti-citrullinated
protein antibody; MTX: methotrexate; GC: glucocorticoid; IFX: infliximab;
ETN: etanercept; CZP: certolizumab pegol; TOF: tofacitinib; CRP:
C-reactive protein; ESR: erythrocyte sedimentation rate; SDAI: simplified
disease activity index.
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The mean measured values determined by the three observ-
ers were used for analysis. To investigate intra-observer
reliability, osteophyte size was measured twice with a 2-
week interval, with the observers blinded to the previous
measurements as well as subject ID and background infor-
mation. For interobserver reliability, each was blinded to the
results obtained by the other observers. Since 2014, we have
routinely examined CT images obtained prior to performing
TKA. Using CT results of 27 cases obtained preoperatively,
osteophyte size was compared between radiograph and CT
coronal images, with the images enlarged so as to evaluate
the accuracy of the measurements. The sizes of osteophytes
in the medial and lateral compartment were determined as
the sum of the osteophyte areas in the medial (MTþMF) and
lateral (LTþLF) sites. Total size was determined as the sum
of the measured sizes in each site.
Statistical analysis
A Kolmogorov–Smirnov test was performed to examine
the distribution of data, with values expressed as the mean
+ SD or median (Inter Quartile Range: IQR), as indicated
in the figure legends. All obtained data were evaluated
using a Wilcoxon-signed rank test, Spearman’s rank corre-
lation coefficient, Jonckheere–Terpstra test, Kruskal–
Wallis test, Bonferroni test, and Mann–Whitney U test. The
values of p < 0.05 were considered to indicate statistical
significance. All statistical analyses were performed using
EZR (Saitama Medical Center, Jichi Medical University,
Saitama, Japan), a graphical user interface for R (The R
Foundation for Statistical Computing, Vienna, Austria),
which is a modified version of the R commander designed
to add statistical functions frequently used for biostatistics.11
Results
Study population characteristics
Mean patient age at the time of the operation was 63.0+
9.80 years, and median disease duration was 15 years
(range 12–25.5 years), while the rates of MTX, glucocorti-
coid, and DMARDs usage were 57.1%, 51.4%, and 37.1%,
respectively. Preoperative Larsen grade was 2, 3, 4, and
5 in 1, 12, 18, and 2 patients, respectively, and the mean
range of motion of the knee joint was 118 for flexion and
10 for extension. The mean femorotibial angle (FTA)
was 178 + 13.6, with varus (FTA > 180, n ¼ 14) more
frequent than valgus (FTA < 170, n ¼ 7) cases (Figure 2).
Inter- and intra-observer reliability, and comparison
of CT images and OARSI grading
Table 2 presents the results regarding inter- and intra-
observer reliability for the measurement method. In each
region, ICC was >0.70, and thus, we concluded that the
method used was reliable. Osteophyte size was largest in
the MF region (37.2, 26.3–62.1 mm2), followed in order by
the LF (27.2, 10.7–41.1 mm2), MT (17.0, 9.12–35.9 mm2),
and LT (4.57, 0.66–19.1 mm2) regions. Furthermore, osteo-
phyte size was significantly larger in the medial than the
lateral compartment (60.8 (34.6–104.6) vs. 30.6 (13.0–
68.6) mm2; Wilcoxon-signed rank test, p < 0.001). In the
CT images (n ¼ 27), a strong correlation was observed for
each region (MF: r ¼ 0.756, p < 0.001; MT: r ¼ 0.804,
p < 0.001; LF: r ¼ 0.711, p < 0.001; LT: r ¼ 0.816,
p < 0.001; Spearman’s rank correlation coefficient)
(Figure 3), which indicated that osteophyte size could be
accurately measured by the present method using
Figure 1. Measurement of Oph size using radiography findings.
Osteophytes are shown encircled by white-dotted lines. Each
osteophyte area was examined and the size calculated using the size
of a calibration ball as a reference. Oph size (mm2) ¼ (Oph (pixel)/
calibration ball (pixel))  p (12.7)2. Oph: osteophyte.
Figure 2. Histogram showing frequency of FTA. Normal align-
ment (170 < FTA < 180) was most common in the present
patients, though there were more varus alignment than valgus
alignment cases. FTA: femora-tibial angle.
Table 2. Inter- and intra-observer reliability for each region.
Region
Interobserver reliability Intra-observer reliability
ICC 95%CI ICC 95%CI
MF 0.945 0.918–0.958 0.944 0.902–0.963
MT 0.733 0.616–0.800 0.781 0.625–0.853
LF 0.758 0.650–0.818 0.767 0.603–0.844
LT 0.947 0.922–0.960 0.928 0.874–0.952
ICC: intra-class correlation coefficient; CI: confidence interval; MF: medial
femur; MT: medial tibia; LF: lateral femur; LT: lateral tibia.
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radiograph images. In comparison with OARSI grade, each
region showed a significant increasing tendency by grade
(Jonckheere–Terpstra test; all sites, p < 0.001) (Figure 4),
again confirming that osteophyte size could be accurately
quantified by use of this method.
Correlation between osteophyte size and various
factors
There was no significant correlation of osteophyte size with
age, gender, disease duration, or range of motion. Given that
FTA was correlated with osteophyte size in the medial com-
partment (Spearman’s correlation coefficient, r¼ 0.493, p¼
0.0026), and FTA was found to have effects on osteophyte
size and region, we divided the present cohort into varus
(FTA  180), normal (FTA 170–180), and valgus (FTA
< 170) groups. In the varus group, osteophyte size in the
medial compartment was significantly greater than the nor-
mal and valgus groups (Kruskal–Wallis test, p ¼ 0.0016;
Bonferroni test, p ¼ 0.375, p ¼ 0.0019). On the other hand,
osteophyte size in the lateral compartment was not signifi-
cantly different in terms of alignment among the three
groups (p ¼ 0.13) (Figure 5). Osteophyte size in the medial
compartment (especiallyMF) was negatively correlated with
inflammatory markers, such as CRP and ESR (Spearman’s
rank correlation coefficient; CRP: r ¼ 0.492, p ¼ 0.0027;
ESR: r ¼ 0.529, p ¼ 0.0016), whereas that size in the
lateral compartment was negatively correlated with disease
activity (Spearman’s rank correlation coefficient; r ¼
0.589, p ¼ 0.0023) (Table 3). As for administered drugs,
there was no significant difference regarding use of MTX or
glucocorticoids, whereas total osteophyte size was signifi-
cantly dominant (Mann–Whitney U test, p ¼ 0.0067) in
patients who received biological DMARDs for more than
1 year (n ¼ 11, Tumor Necrosis Factor (TNF)-alpha inhibi-
tors in all) (Table 4).
Multiple linear regression analysis was performed to
reveal the relationship of total osteophyte size with age
(over 60 years), malalignment (FTA < 170 or FTA >
180), high inflammation (CRP > 0.5), disease duration
(over 20 years), and moderate disease activity (SDAI
>11), as well as biological DMARD (>1 year, n ¼ 11),
MTX (n ¼ 20), and glucocorticoid (n ¼ 18) usage. Those
results showed that both biological DMARDs use and
malalignment had a significant association with total osteo-
phyte size (Table 5).
Figure 3. Scatter plot showing correlation of Oph size with CT and radiography (X-p) findings in each site. In all sites, osteophyte size was
strongly correlated with both CT and X-p (LF: r¼ 0.711, p < 0.001; LT: r¼ 0.816, p < 0.001; MF: r¼ 0.757, p < 0.001; and MT: r¼ 0.804,
p < 0.001). Oph: osteophyte; CT: computed tomography; LF: lateral femur; LT: lateral tibia; MF: medial femur; MT: medial tibia.
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Discussion
We attempted to quantify osteophyte size using radio-
graphy results and also examined the relationship with
RA pathology. Osteophyte size determined according
to the present measurement method was strongly cor-
related with CT image results, while that has also pre-
viously been shown to be significantly correlated with
a semi-quantification method based on the OARSI
score, a conventional methodology. Based on our find-
ings, we consider that osteophyte size can be accu-
rately determined using the present measurement
method. In addition, our analysis of quantified size
showed that osteophytes occurring in the medial com-
partment were large in varus alignment cases, indicat-
ing that disease activity and DMARDs have effects on
osteophyte size.
Figure 4. Box plot showing relationship between Oph size and OARSI grade in each site. Median values are presented. Oph:
osteophyte; OARSI: Osteoarthritis Research Society International; MF: medial femur; MT: medial tibia; LF: lateral femur; LT: lateral tibia.
Figure 5. Box plot showing relationship between FTA and Oph size in medial (a) and lateral (b) compartments. Osteophyte size in the
medial compartment was significantly larger in varus alignment cases, while there was no difference in osteophyte size in the lateral
compartment. FTA: femora-tibial angle; Oph: osteophyte.
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Osteophyte formation in the medial compartment has
been reported to worsen varus alignment in knees with
OA.12 In the present cohort, osteophyte size in the medial
compartment was significantly greater in knees with varus
alignment than to normal knees and those with valgus
alignment, suggesting that secondary OA progresses in the
knees of RA patients. Since the introduction of DMARDs,
including biologics, findings have shown dramatic suppres-
sion of bone destruction progress in treated RA patients.13
However, it is difficult to completely prevent the progress
of joint destruction in a loading joint with a high Larsen
grade, even when biological DMARDs treatment is used,14
resulting in no repair of cartilage destruction due to acute
phase arthritis, leading to secondary OA progression.
Based on the present findings showing that inflammatory
markers and osteophyte size in the medial compartment
had a negative correlation, we consider that secondary
OA progression occurs only in RA knees with RA with
sufficiently controlled inflammation.
In the lateral compartment, a significantly negative cor-
relation was seen between osteophyte size and disease
activity. Osteophyte formation in that compartment, which
is often observed in lateral OA but relatively rarely in med-
ial OA cases, is thought to react to traction.12 Cartilage
destruction in RA knees is accompanied by synovitis and
occurs relatively evenly on the medial and lateral sides, and
thus, alignment is maintained or slightly valgus in many
cases, while valgus deformity tends to progress as Larsen
grade increases.15 When disease activity is not controlled in
cases with valgus deformity, osteophyte formation does not
occur, similar to lateral OA cases, whereas osteophyte for-
mation in the lateral compartment occurs due to traction in
cases with varus alignment. Therefore, osteophyte size in
the lateral compartment was not found to be correlated with
alignment or inflammatory markers.
Treatments with biological DMARDs and MTX have
influence on osteophyte size, possibly due to sufficient
control of synovitis. On the other hand, the use of gluco-
corticoids did not influence osteophyte formation in the
present cases. Thus, the effects of glucocorticoids on bone
resorption, such as osteoporotic and bone density lowering
effects,16 are stronger than the arthritis suppression effects.
Bone destruction in RA is associated with activation of
osteoclasts by RANKL,17 and MTX and biological
DMARDs prevent progression of bone destruction by nor-
malizing osteoclast activation by inflammatory cytokines.
These findings suggest that osteoclast activity is affected
by osteophyte formation in RA and osteophyte formation is
expected to progress in cases where bone resorption is
suppressed. In addition, the significantly greater osteophyte
size shown in the group using TNF-alpha inhibitors may
reflect a direct effect of TNF-alpha on bone formation.
Since TNF-alpha has an inhibitory effect on osteogenesis
Table 3. Correlation of osteophyte size with inflammation markers and disease activity.a
CRP ESR SDAI
r p r p r p
Medial compartment (MFþMT) 0.367 0.030 0.42 0.015 0.198 n.s.
MF 0.492 0.0027 0.529 0.0016 0.298 n.s.
MT 0.198 n.s. 0.201 n.s. 0.173 n.s.
Lateral compartment (LFþLT) 0.322 n.s. 0.188 n.s. 0.589 0.0023
LF 0.239 n.s. 0.13 n.s. 0.581 0.0023
LT 0.256 n.s. 0.164 n.s. 0.489 0.013
Total 0.394 0.019 0.323 n.s. 0.474 0.018
CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; SDAI: simplified disease activity index; MF: medial femur; MT: medial tibia; LF: lateral
femur; LT: lateral tibia.
aSpearman’s correlation coefficients with p-values. Strongly correlated areas are shown in bold.
Table 4. Total Oph size and effects of drugs.a
Total Oph size (mm2), median (IQR)
p-ValueUse over 1 year No or <1 year use
MTX 115 (58.8–172) 85.5 (79.1–130) n.s.
Oral GCs 89.2 (71.5–146) 101 (76.5–143) n.s.
Biologics 140 (110–191) 81.8 (58.8–129) 0.0067
Oph: osteophyte; MTX: methotrexate; GCs: glucocorticoids; DMARDs:
disease-modifying anti-rheumatic drugs.
aThere was a significant difference in total osteophyte size when biological
DMARDs were used for more than 1 year. Median values (IQR) are
presented.
Table 5. Multiple linear regression analysis.a
b SE p-Value
(Intercept) 0.909 38.26 0.9813
Biologics use 103.8 38.22 0.0129
Malalignment 91.39 34.87 0.0160
MTX use 68.81 35.73 0.0677
R2 ¼ 0.3438
FTA: femora-tibial angle; MTX: methotrexate; DMARDs: disease-
modifying anti-rheumatic drugs.
aBiological DMARDs use and malalignment were significant predictors of
total osteophyte size. Malalignment (FTA < 170 or FTA > 180).
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through Dkk-1, which inhibits Wnt signaling, it is possible
that osteogenesis can be promoted by decreasing TNF-
alpha by use of a TNF-alpha inhibitor.18
Osteophyte formation leads to joint stability, which alle-
viates pain and improves activities of daily living. On the
other hand, such formation in the knee has been reported to
increase pain and the rate of incidence of TKA surgery.19 It
is anticipated that the number of patients using biological
DMARDs will substantially increase in the future. Consid-
ering that the incidence of joint replacement surgery has
not decreased since introduction of biological DMARDs,20
it is a possible that RA patients undergoing joint replace-
ment surgery for secondary OA will continue to increase.
Our study has several limitations. The design was not
prospective, and radiography findings were not evaluated
at the start of treatment; thus, results showing the influence
of administered drugs on osteophyte formation may be
limited. In addition, some of the present patients had
elderly onset RA, and the possibility that preexisting pri-
mary OA in the knees of these patients before the onset of
RA cannot be denied.
Conclusion
In summary, osteophyte size in RA-TKA cases was quan-
tified using radiography results and the morphology ana-
lyzed. In knees with varus alignment, osteophyte size in the
medial compartment was large, indicating that secondary
OA is more prominent in patients with controlled inflam-
mation. Disease activity associated with RA was also
shown to have an effect on osteophyte size and that could
also be influenced by the type of administered drugs
received, including the possibility that osteophyte size is
affected by DMARDs rather than glucocorticoids.
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